MedTrace Logo

Exercise and Vascular Function in Haemodialysis Patients

NCT01591876 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-03-01

No results posted yet for this study

Summary

The aim of this study is to evaluate whether a three month intra-dialytic exercise programme improves arterial function.

Conditions

  • Chronic Kidney Disease Stage 5

Interventions

OTHER

Intradialytic aerobic exercise

Participants in the intervention group will undertake moderate intensity aerobic exercise. Exercise modality will be recumbent cycling during the first two hours of haemodialysis sessions. Exercise prescription is set using a graded exercise test and anchored to a perceived level of exertion using the BORG scale. Training stimulus is maintained by the participant by increasing the cycling resistance when perceived exertion drops by one point at the current resistance level. Adherence and training volume is recorded during the intervention period.

OTHER

Progressive Muscle relaxation

This is a sequence of stretching and relaxation of the major muscle groups of the body. Participants are initially given detailed information regarding the technique and then provided with a recorded version which they listen to for 30-40 minutes during dialysis sessions. Participants in this group are offered the exercise programme at the end of three months.

Sponsors & Collaborators

  • British Kidney Patients Association

    collaborator UNKNOWN

  • Queen Margaret University

    lead OTHER

Principal Investigators

  • Tom Mercer, Professor · Queen Margaret University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-07-31
Completion
2014-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01591876 on ClinicalTrials.gov